Bradley Tran, MD
Pain Management · Jacksonville, FLNPI 1366445991
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $6,359 of the $7,825 with a category attached, or 81.3%. 43 manufacturers reported payments, led by Abbott at 24.6% of the total. Reporting peaked in 2024 at $2,716 and has fallen 96.8% since, to $88 in 2025.
Across 303 payments — averaging $25.83 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Abbott$2K
- Boston Scientific$1K
- Amgen$588
- Sanofi$441
- AbbVie$432
- Novartis$286
- plus $3K from 37 others
What the payments were for
- Travel & lodging$1,46619%
- Food & beverage$6,35981%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- PROCLAIM$1,290
- Intracept$458
- ETERNA$183
- Evoke SCS$143
- Licart$124
- PNS FREEDOM-4A PERMANENT NEUROSTIMULATOR RECEIVER KIT CHANNEL A$123
- SPRINT PNS System$120
How this compares
Too few pain management providers in Floridato place this figure against a meaningful peer group, so we don't.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen | 113 | $41,867 |
| Xtampza ErOxycodone Myristate | 26 | $12,811 |
| Oxycodone Hcl | 244 | $6,275 |
| OxycontinOxycodone Hcl | 14 | $4,656 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 95 | $3,362 |
| Morphine Sulfate ErMorphine Sulfate | 73 | $1,667 |
| Gabapentin | 88 | $1,226 |
| Lidocaine | 17 | $1,212 |
| Morphine Sulfate | 29 | $1,134 |
| Pregabalin | 51 | $1,130 |
| Tizanidine Hcl | 46 | $297 |
| Hydromorphone Hcl | 12 | $270 |
| Ondansetron OdtOndansetron | 13 | $262 |
| Cyclobenzaprine Hcl | 47 | $201 |
| Methadone Hcl | 11 | $196 |
Paid to pharmacies, not to this prescriber.
Other pain management in Jacksonville
- Hagop TabakianJacksonville$0
- Keisha Smith-ReadJacksonville$0
- Bruce PiszelBrandon$3K
- Lamvien NguyenMary Esther$2K
- Susan GormleyTallahassee$326
- Mikhail FiksmanHollywood$18
- Murali AngirekulaBeverly Hills$0
- Frederick WeissDeland$0
- Noah ResutaNaples$0
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.